Cargando…
A multicenter, double-blind, randomized trial on the bleeding profile of a drospirenone-only pill 4 mg over nine cycles in comparison with desogestrel 0.075 mg
PURPOSE: A typical compliance problem in the use of traditional progestin-only pills is the irregular bleeding pattern and the strict daily intake. Desogestrel 75 mg has a 12-h missed-pill window; however, its poor cycle control limits a more common use. METHODS: A drospirenone (DRSP)-only pill was...
Autores principales: | Palacios, Santiago, Colli, Enrico, Regidor, Pedro-Antonio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7174261/ https://www.ncbi.nlm.nih.gov/pubmed/31728664 http://dx.doi.org/10.1007/s00404-019-05340-4 |
Ejemplares similares
-
Bleeding profile of women using a drospirenone-only pill 4 mg over nine cycles in comparison with desogestrel 0.075 mg
por: Palacios, S., et al.
Publicado: (2020) -
Correction to: A multicenter, double-blind, randomized trial on the bleeding profle of a drospirenone-only pill 4 mg over nine cycles in comparison with desogestrel 0.075 mg
por: Palacios, Santiago, et al.
Publicado: (2020) -
Multicenter, phase III trials on the contraceptive efficacy, tolerability and safety of a new drospirenone‐only pill
por: Palacios, Santiago, et al.
Publicado: (2019) -
Efficacy and cardiovascular safety of the new estrogen-free contraceptive pill containing 4 mg drospirenone alone in a 24/4 regime
por: Palacios, Santiago, et al.
Publicado: (2020) -
An Oral Contraceptive Containing Estetrol 15 MG and Drospirenone 3 MG Has Limited Effects on Endocrine and Metabolic Parameters
por: Klipping, Christine, et al.
Publicado: (2021)